Vincenzo Mazzaferro
#117,834
Most Influential Person Now
Researcher
Vincenzo Mazzaferro's AcademicInfluence.com Rankings
Vincenzo Mazzaferrocomputer-science Degrees
Computer Science
#4652
World Rank
#4908
Historical Rank
Machine Learning
#979
World Rank
#994
Historical Rank
Artificial Intelligence
#1202
World Rank
#1224
Historical Rank
Database
#1859
World Rank
#1950
Historical Rank
Download Badge
Computer Science
Vincenzo Mazzaferro's Degrees
- PhD Computer Science University of Milan
- Masters Computer Science University of Milan
- Bachelors Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Vincenzo Mazzaferro Influential?
(Suggest an Edit or Addition)Vincenzo Mazzaferro's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Sorafenib in advanced hepatocellular carcinoma. (2008) (5771)
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. (2018) (5681)
- Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. (1996) (3677)
- EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. (2012) (3188)
- EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. (2012) (2654)
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. (2009) (1584)
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets (2015) (1253)
- Hepatocellular carcinoma: clinical frontiers and perspectives (2014) (1187)
- Gene expression in fixed tissues and outcome in hepatocellular carcinoma. (2008) (1158)
- Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study (2020) (980)
- Resection and liver transplantation for hepatocellular carcinoma. (2005) (854)
- miR-221 overexpression contributes to liver tumorigenesis (2009) (730)
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. (2012) (707)
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. (2015) (697)
- Pivotal role of mTOR signaling in hepatocellular carcinoma. (2008) (675)
- Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma (2007) (645)
- Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. (2008) (566)
- Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions (2012) (554)
- Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features. (2017) (545)
- Radiofrequency Ablation of Small Hepatocellular Carcinoma in Cirrhotic Patients Awaiting Liver Transplantation: A Prospective Study (2004) (500)
- Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. (2011) (490)
- Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence‐based analysis of 15 years of experience (2011) (475)
- Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. (2013) (418)
- Yttrium‐90 radioembolization for intermediate‐advanced hepatocellular carcinoma: A phase 2 study (2013) (405)
- A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. (2006) (381)
- Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. (2011) (378)
- Prevention of hepatocellular carcinoma recurrence with alpha‐interferon after liver resection in HCV cirrhosis (2006) (347)
- Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma. (2018) (344)
- Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease (2018) (324)
- Resection of hepatocellular cancer ≤2 cm: Results from two Western centers (2013) (306)
- DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma (2015) (304)
- Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial (2015) (301)
- Immunotherapies for hepatocellular carcinoma (2021) (287)
- Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. (2018) (268)
- Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer. (2003) (259)
- Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? (2007) (256)
- Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study. (2018) (249)
- Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma (2015) (242)
- Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma (2018) (237)
- COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy (2020) (229)
- IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. (2010) (228)
- Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. (2009) (227)
- MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. (2011) (223)
- Efficacy of liver transplantation in patients with primary biliary cirrhosis. (1989) (221)
- Hepatic artery thrombosis after pediatric liver transplantation--a medical or surgical event? (1989) (220)
- Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment (2016) (217)
- Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study. (2013) (215)
- Liver cancer: Approaching a personalized care. (2015) (210)
- Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma (2015) (179)
- The Place of Liver Transplantation in the Treatment of Hepatic Epitheloid Hemangioendothelioma: Report of the European Liver Transplant Registry (2007) (166)
- Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial (2018) (160)
- Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis (2010) (156)
- Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: Biological lessons, current challenges, and clinical perspectives (2013) (153)
- Chordoma: Natural history and treatment results in 33 cases (1988) (151)
- A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma (2010) (148)
- A Multistep, Consensus‐Based Approach to Organ Allocation in Liver Transplantation: Toward a “Blended Principle Model” (2015) (147)
- Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. (1998) (147)
- Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib (2012) (143)
- The effect of estrogen and tamoxifen on hepatocyte proliferation in Vivo and in Vitro (1989) (136)
- Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment. (2001) (135)
- Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations (2017) (135)
- Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: Effect of liver transplantation (2000) (133)
- Human Tumor-Derived Heat Shock Protein 96 Mediates In Vitro Activation and In Vivo Expansion of Melanoma- and Colon Carcinoma-Specific T Cells1 (2003) (130)
- Liver Transplantation for Hepatocellular Carcinoma (2008) (129)
- Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma (2016) (128)
- Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer (2004) (127)
- Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan. (2011) (126)
- Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: a case-control study. (2013) (124)
- The Long‐Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors (2016) (120)
- Radioembolization of hepatocarcinoma with 90Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology (2015) (116)
- Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. (1989) (115)
- Gene-expression signature of vascular invasion in hepatocellular carcinoma. (2011) (115)
- Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. (2012) (115)
- The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality (2021) (114)
- Liver resection and transplantation for intrahepatic cholangiocarcinoma. (2020) (112)
- Regulation of glucose homeostasis in humans with denervated livers. (1997) (111)
- Split and whole liver transplantation outcomes: A comparative cohort study (2006) (110)
- Childbearing after liver transplantation. (1990) (105)
- Unique genomic profile of fibrolamellar hepatocellular carcinoma. (2015) (104)
- Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses. (2012) (103)
- Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination. (1997) (101)
- Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma (2018) (99)
- Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach (2016) (99)
- Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial. (2020) (92)
- Resection versus transplantation for liver metastases from neuroendocrine tumors. (2001) (91)
- Balancing Donor and Recipient Risk Factors in Liver Transplantation: The Value of D‐MELD With Particular Reference to HCV Recipients (2011) (90)
- Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion. (2018) (88)
- Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. (2007) (86)
- Liver transplantation in patients with previous portasystemic shunt. (1990) (84)
- A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group. (1995) (84)
- Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle. (2010) (83)
- Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. (2004) (83)
- Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma. (2016) (82)
- Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy (2014) (81)
- A clinicopathologic study of primary hepatic carcinoid tumors (1990) (80)
- Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine‐resistant mutants (2005) (77)
- Nonhepatic glucose production in humans. (2004) (76)
- Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis. (2017) (75)
- Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice. (2019) (75)
- Percutaneous Transhepatic Biliary Drainage in the Management of Postsurgical Biliary Leaks in Patients with Nondilated Intrahepatic Bile Ducts (2006) (74)
- Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. (1996) (74)
- Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in child-pugh b cirrhosis. (2020) (73)
- Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. (2011) (72)
- Liver transplantation for neuroendocrine tumour liver metastases. (2015) (70)
- Results of liver transplantation: With or without milan criteria? (2007) (70)
- Heat Shock Proteins and Their Use as Anticancer Vaccines (2004) (68)
- Drug‐eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma (2016) (66)
- A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres. (2012) (66)
- Occurrence of cytomegalovirus hepatitis in liver transplant patients (1988) (65)
- Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry (2017) (65)
- Impact of home enteral nutrition in malnourished patients with upper gastrointestinal cancer: A multicentre randomised clinical trial. (2016) (64)
- Early Hepatocellular Carcinoma on the Procrustean Bed of Ablation, Resection, and Transplantation (2014) (62)
- Importance of early nutritional screening in patients with gastric cancer (2011) (61)
- Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies (2018) (60)
- Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation (2019) (60)
- First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant Fibroblast Growth Factor 19 Signaling as a Driver Event in Hepatocellular Carcinoma. (2019) (59)
- STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC) (2014) (58)
- Liver transplantation for small hepatocellular carcinoma in cirrhosis: analysis of our experience. (2001) (58)
- Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study. (2014) (58)
- Toward a Better Liver Graft Allocation That Accounts for Candidates With and Without Hepatocellular Carcinoma (2014) (58)
- Transarterial Chemoembolization for Hepatocellular Carcinoma with a New Generation of Beads: Clinical–Radiological Outcomes and Safety Profile (2015) (57)
- When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations. (2015) (57)
- Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma (2012) (57)
- Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses (2016) (57)
- Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study. (1999) (57)
- Hepatotrophic effects of FK506 in dogs. (1991) (57)
- Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis (2016) (56)
- Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure. (2008) (56)
- Hormonal and enzymatic parameters of hepatic regeneration in patients undergoing major liver resections (1990) (56)
- Milan multicenter experience in liver transplantation for hepatocellular carcinoma. (1994) (56)
- Experience with radiofrequency ablation of small hepatocellular carcinomas before liver transplantation. (2001) (56)
- Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: A review and consensus statement (2011) (56)
- pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma (2018) (55)
- Evidence of Distinct Tumour-Propagating Cell Populations with Different Properties in Primary Human Hepatocellular Carcinoma (2011) (55)
- Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation. (2015) (54)
- Effect of age on survival in patients undergoing resection of hepatocellular carcinoma (2016) (54)
- Duodenal Fistula after Elective Gastrectomy for Malignant Disease (2010) (53)
- Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. (1987) (52)
- Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver. (2017) (51)
- Metabolic effects of liver transplantation in cirrhotic patients. (1997) (51)
- Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. (2018) (50)
- Factors responsible for hepatic artery thrombosis after pediatric liver transplantation. (1989) (50)
- Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials (2019) (49)
- Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96. (2005) (49)
- Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma (2018) (48)
- The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis (2010) (47)
- Liver transplantation for unresectable hepatocellular carcinoma in normal livers. (2012) (45)
- Living donor liver transplantation for hepatocellular carcinoma exceeding conventional criteria: Questions, answers and demands for a common language (2006) (45)
- Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference. (2020) (45)
- The hepatotropic influence of cyclosporine. (1990) (44)
- Resting energy expenditure in diabetic and nondiabetic patients with liver cirrhosis: relation with insulin sensitivity and effect of liver transplantation and immunosuppressive therapy. (2002) (44)
- mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors. (2020) (44)
- Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant. (2020) (43)
- Prognostic role of pancreatic metastases from renal cell carcinoma: results from an Italian center. (2013) (43)
- A Prospective Policy Development to Increase Split-Liver Transplantation for 2 Adult Recipients: Results of a 12-Year Multicenter Collaborative Study (2014) (43)
- Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study. (2021) (42)
- The SIRveNIB and SARAH trials, radioembolization vs. sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future. (2018) (41)
- Morbidity and mortality after surgical resection of liver tumors. Analysis of 229 cases. (1992) (40)
- Donor safety in living donor liver donation: An Italian multicenter survey (2017) (40)
- Second-line tivantinib (ARQ 197) vs placebo in patients (Pts) with MET-high hepatocellular carcinoma (HCC): Results of the METIV-HCC phase III trial. (2017) (40)
- Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant (2020) (39)
- Estradiol and testosterone levels in patients undergoing partial hepatectomy (1989) (39)
- Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry (2018) (38)
- Partial hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: Confirming the trial that will never be, and some comments on the indications for liver resection (2010) (38)
- Vascular invasion and survival after liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry. (2018) (37)
- Prolongation of Pig‐to‐Dog Renal Xenograft Survival by Modification of the Inflammatory Mediator Response (1987) (37)
- Pharmacologic Modulation of Experimental Postischemic Hepatic Function (1989) (37)
- Locoregional treatments before liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry (2018) (36)
- Current challenges in liver transplantation for hepatocellular carcinoma. (2014) (35)
- Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver (1991) (35)
- Confirmation of graft-versus-host disease after liver transplantation by PCR HLA-typing. (1993) (35)
- Solid-pseudopapillary tumor of the pancreas (Frantz tumor) in children. (2003) (35)
- Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy. (2021) (34)
- Heterologous and cross-species tropism of cancer-derived extracellular vesicles (2019) (34)
- 3507 ORAL Sorafenib improves survival in a large multi-center, randomized, placebo-controlled phase III trial in patients with hepatocellular carcinoma (2007) (33)
- ARQ 087, an oral pan-fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced intrahepatic cholangiocarcinoma (iCCA) with FGFR2 genetic aberrations. (2017) (33)
- A national mandatory‐split liver policy: A report from the Italian experience (2019) (33)
- The surgical implications of the posttransplant lymphoproliferative disorders. (1991) (32)
- Preliminary Analysis of the Impact of the Coronavirus Disease 2019 Outbreak on Italian Liver Transplant Programs (2020) (32)
- 579 MIR-221 OVEREXPRESSION CONTRIBUTES TO LIVER TUMORIGENESIS (2010) (31)
- Fibroblastic reticular cell tumor of the spleen: report of a case and review of the entity. (2003) (31)
- 8. Multidisciplinary Approach for the Treatment of Neuroendocrine Tumors (2010) (31)
- The chances of hepatic resection curing hepatocellular carcinoma. (2019) (31)
- Inducing tolerability of adverse events increases sorafenib exposure and optimizes patient's outcome in advanced hepatocellular carcinoma (2016) (31)
- FK 506 as a growth control factor. (1990) (30)
- Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification (2022) (30)
- The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE) (2014) (29)
- Renal artery reconstruction for harvesting injuries in kidney transplantation with particular reference to the use of vascular allografts (1988) (29)
- Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma. (2021) (28)
- Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes. (2016) (28)
- Principles for the best multidisciplinary meetings. (2011) (28)
- Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion – a multi‐center retrospective cohort study (2020) (27)
- Radioembolization of hepatocarcinoma with 90Y glass microspheres: treatment optimization using the dose-toxicity relationship (2020) (27)
- Endoscopic ultrasound-guided esophagoenterostomy for a completely obstructed surgical anastomosis (2016) (26)
- hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis (1990) (24)
- Rapid Flush Technique for Donor Hepatectomy: Safety and Efficacy of an Improved Method of Liver Recovery for Transplantation. (1988) (24)
- Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study (2021) (24)
- Orthotopic liver transplantation for massive hepatic lymphangiomatosis. (1988) (24)
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and vascular invasion or extrahepatic spread: A subanalysis from the SHARP trial (2008) (24)
- Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma (2017) (24)
- Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases (2015) (23)
- DNA Methylation Profiling of Human Hepatocarcinogenesis (2020) (23)
- Surgical management of duodenal stump fistula after elective gastrectomy for malignancy: an Italian retrospective multicenter study (2014) (23)
- Should a History of Extraperitoneal Disease Be a Contraindication to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases? (2018) (23)
- Feasibility of Peritonectomy Associated with Intraperitoneal Hyperthermic Perfusion in Patients with Pseudomyxoma Peritonei (2002) (23)
- Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma (2020) (23)
- Resection, transplantation, either, or both? Other pieces of the puzzle (2005) (22)
- Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis. Primary hepatocellular carcinoma is not a predictor for HBV recurrence. The European Cooperative Study Group on Liver Cancer and Transplantation. (2008) (22)
- Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma (2017) (21)
- Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan (2020) (21)
- Thyroid as a Target of Metastases. A Case of Foregut Neuroendocrine Carcinoma with Multiple Abdominal Metastases and a Thyroid Localization after 21 Years (2008) (21)
- Surgical resection for hepatocellular carcinoma: Moving from what can be done to what is worth doing (2015) (21)
- Intrahepatic Flow Redistribution in Patients Treated with Radioembolization (2015) (21)
- Studies of the hepatotrophic qualities of FK 506 and CyA. (1990) (21)
- Microenvironment and tumor inflammatory features improve prognostic prediction in gastro‐entero‐pancreatic neuroendocrine neoplasms (2019) (21)
- The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors: Pros and cons (2017) (20)
- Risk‐adjusted benchmarks in laparoscopic liver surgery in a national cohort (2020) (20)
- Assessment of insulin sensitivity based on a fasting blood sample in men with liver cirrhosis before and after liver transplantation1 (2003) (20)
- The Italian Consensus on minimally invasive simultaneous resections for synchronous liver metastasis and primary colorectal cancer: A Delphi methodology (2021) (19)
- Multicenter validation of a score to predict prognosis after the development of HCC recurrence following liver transplantation. (2019) (19)
- Permanent Pancreatic Duct Occlusion With Neoprene-based Glue Injection After Pancreatoduodenectomy at High Risk of Pancreatic Fistula (2019) (19)
- Thoracic paravertebral anesthesia for percutaneous radiofrequency ablation of hepatic tumors. (2014) (18)
- Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications (2022) (18)
- Liver Retransplantation in Adults: The Largest Multicenter Italian Study (2012) (18)
- Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery (2020) (17)
- TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study (2021) (17)
- Efficacy of derazantinib (DZB) in patients (pts) with intrahepatic cholangiocarcinoma (iCCA) expressing FGFR2-fusion or FGFR2 mutations/amplifications (2019) (17)
- First-line treatment for hepatocellular carcinoma: resection or transplantation? (2007) (17)
- Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1–FEV translocation (2014) (17)
- The role of somatostatin analogues in the treatment of gastro-enteropancreatic endocrine tumours. (1996) (16)
- Further steps of hepatic stimulatory substance purification (1991) (16)
- Spontaneous hypoglycaemia after pancreas transplantation in Type 1 diabetes mellitus (1998) (16)
- A matched pair analysis of multicenter longterm follow‐up after split‐liver transplantation with extended right grafts (2017) (16)
- Management of biliary anastomotic strictures after liver transplantation (BASALT study): A nationwide Italian survey (2017) (16)
- 365OPhase 1 safety and clinical activity of BLU-554 in advanced hepatocellular carcinoma (HCC) (2017) (16)
- 6576 POSTER Phase II Safety Study of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as Second-line Therapy in Patients With Hepatocellular Carcinoma (2011) (16)
- Dissecting EASL/AASLD Recommendations With a More Careful Knife: A Comment on "Surgical Misinterpretation" of the BCLC Staging System. (2015) (16)
- Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials (2018) (16)
- Antitumor Activity of a Novel Fibroblast Growth Factor Receptor (FGFR) Inhibitor for Intrahepatic Cholangiocarcinoma. (2019) (16)
- Transplant Oncology in Primary and Metastatic Liver Tumor: Principles, Evidence and Opportunities. (2020) (16)
- Repeated transarterial chemoembolization: An overfitting effort? (2015) (16)
- A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors (2018) (16)
- Endo‐therapies for biliary duct‐to‐duct anastomotic stricture after liver transplantation: Outcomes of a nationwide survey (2019) (15)
- Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients (2017) (15)
- Simultaneous characterization of progenitor cell compartments in adult human liver (2009) (15)
- Transplantation of autologous extracellular vesicles for cancer-specific targeting (2021) (15)
- Pro (With Caution): Extended oncologic indications in liver transplantation (2018) (15)
- Recurrence of desmoid tumor in a multivisceral transplant patient with Gardner's syndrome. (1999) (15)
- Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs) (2019) (14)
- Extended Oncologic Indications in Liver Transplantation: PRO (with caution). (2017) (14)
- Prognostic factors in patients affected by hepatocellular carcinoma treated with systemic chemotherapy: the experience of the National Cancer Institute of Milan. (1993) (14)
- Spontaneous Massive Necrosis of a Hepatocellular Carcinoma (1987) (13)
- Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma (2018) (13)
- A Longitudinal Investigation of Posttraumatic Growth and Quality of Life in Liver Transplant Recipients (2018) (13)
- Effect of 15-deoxyspergualin on experimental organ transplantation. (1988) (13)
- A Combined Approach to Priorities of Surgical Oncology During the COVID-19 Epidemic. (2020) (13)
- Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases (2017) (13)
- Multicentre evaluation of case volume in minimally invasive hepatectomy (2020) (13)
- Hyperacute rejection of renal discordant xenograft (pig-to-rabbit): model assessment and rejection mechanisms. (1990) (12)
- Immunocytochemical Detection and Characterization of Intrahepatic Human Pancreatic Islets after Combined Liver-Islet Allotransplantation (1994) (12)
- Primary lymphoma of the liver showing immunohistochemical evidence of T-cell origin (1988) (12)
- Ki-67 and presence of liver metastases identify different progression-risk classes in pancreatic neuroendocrine neoplasms (pNEN) undergoing resection. (2019) (12)
- Candidates for liver transplantation for cancer: physical, psychological, and social conditions1 (2002) (12)
- Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis (2018) (12)
- The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: A review. (2021) (12)
- Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft Reinfection (2012) (11)
- Response and relapse rates after treatment with long-acting somatostatin analogs in multifocal or recurrent type-1 gastric carcinoids: A systematic review and meta-analysis (2020) (11)
- Clinical Behavior and Treatment Response of Epstein-Barr Virus-Positive Metastatic Gastric Cancer: Implications for the Development of Future Trials. (2020) (11)
- Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma (2019) (11)
- Mutation and transcription analysis of transthyretin gene in Italian families with hereditary amyloidosis: a putative novel ‘hot spot’ in codon 47 (2000) (11)
- Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study (2021) (11)
- Cabozantinib enhances anti-PD1 activity and elicits a neutrophil-based immune response in hepatocellular carcinoma. (2022) (11)
- Kaposi's sarcoma: malignant tumor or proliferative disorder? (1988) (10)
- Does hyperprolactinemia affect hepatic regeneration independent of sex steroids? (1988) (10)
- LIVER TRANSPLANTATION FOR RECURRENCE AFTER RESECTION OF SOLITARY HEPATOCELLULAR CARCINOMA (1999) (10)
- PD-019ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA). (2016) (10)
- Inflammatory Pseudotumor of the Liver: Report of Two Cases (1990) (10)
- Malignant pheochromocytoma and paraganglioma: future considerations for therapy. (2013) (10)
- Pattern of recurrence of hepatocellular carcinoma after liver transplantation: Milan multicenter experience. (1994) (10)
- The role of wireless capsule endoscopy (WCE) in the detection of occult primary neuroendocrine tumors. (2017) (10)
- Amino acid kinetics during the anhepatic phase of liver transplantation. (2002) (10)
- Evolution in the treatment of gastroenteropancreatic-neuroendocrine neoplasms, focus on systemic therapeutic options: a systematic review. (2015) (10)
- Liver transplantation (OLT) for small hepatocellular carcinoma (HCC) in cirrhosis (1993) (10)
- Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies (2021) (9)
- Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy (2021) (9)
- Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions (2017) (9)
- Gastroblastoma in Adulthood—A Rarity among Rare Cancers—A Case Report and Review of the Literature (2019) (9)
- Development of a prognostic scoring system for resectable hepatocellular carcinoma (2016) (9)
- Proposal of Prognostic Survival Models before and after Liver Resection for Hepatocellular Carcinoma in Potentially Transplantable Patients. (2018) (9)
- CT cholangiography: assessment of feasibility and diagnostic reliability. (2009) (9)
- Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus‐31 nuclear magnetic resonance spectroscopy in vivo (1991) (9)
- Orthotopic liver transplantation for primary biliary tumors: Milan multicenter experience. (1994) (9)
- 45P Efficacy of derazantinib in intrahepatic cholangiocarcinoma patients with FGFR2 mutations or amplifications: Pooled analysis of clinical trials and early access programs (2020) (8)
- Thrombosis after liver transplantation for hepatocellular carcinoma (2017) (8)
- Transhepatic anterior approach to the inferior vena cava in large retroperitoneal tumors resected en bloc with the right liver lobe. (2013) (7)
- Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy. (2017) (7)
- Combined immunotherapy and VEGF-antagonist in hepatocellular carcinoma: a step forward. (2020) (7)
- Alpha‐fetoprotein in liver transplantation for hepatocellular carcinoma: The lower, the better (2018) (7)
- Current practice of normothermic regional perfusion and machine perfusion in donation after circulatory death liver transplants in Italy (2022) (7)
- Role of estrogens and epidermal growth factor in hepatocellular carcinoma (HCC) (1991) (7)
- Loss of succinate dehydrogenase subunit B (SDHB) as a prognostic factor in advanced ileal well-differentiated neuroendocrine tumors (2017) (7)
- Minimally Invasive Stage 1 to Protect Against the Risk of Liver Failure: Results from the Hepatocellular Carcinoma Series of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Italian Registry. (2020) (7)
- One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approaches (2020) (7)
- Insulin independence after islet-liver transplantation for metastatic neuroendocrine pancreatic tumor. (1994) (7)
- Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledge (2019) (7)
- Expert opinion on advanced techniques for hemostasis in liver surgery. (2016) (7)
- A Combined Approach to Priorities of Surgical Oncology During the COVID-19 Epidemic (2020) (7)
- Liver resection for perihilar cholangiocarcinoma: Impact of biliary drainage failure on postoperative outcome. Results of an Italian multicenter study. (2021) (7)
- Renal-splenic shunt for infrahepatic caval occlusion after piggy-back liver transplantation (1997) (7)
- Preoperative predictors of liver decompensation after mini-invasive liver resection (2020) (7)
- The Italian Rare Pancreatic Exocrine Cancer Initiative (2019) (7)
- Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable (2019) (7)
- Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals. (2017) (6)
- Molecular predictors of recurrence prevention with sorafenib as adjuvant therapy in hepatocellular carcinoma: Biomarker study of the STORM phase III trial (2017) (6)
- Succinate Dehydrogenase B Subunit Immunohistochemical Expression Predicts Aggressiveness in Well Differentiated Neuroendocrine Tumors of the Ileum (2012) (6)
- Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation (2021) (6)
- Well-differentiated neuroendocrine tumor of tailgut cyst. A rare entity with controversial medical opportunities. (2013) (6)
- [Use of safety catheter after removal of Kehr's tube in liver transplant patients]. (1995) (6)
- Surgical Management of Hepatic Benign Disease: Have the Number of Liver Resections Increased in the Era of Minimally Invasive Approach? Analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry (2019) (6)
- Reappraisal of surgical treatment of small hepatocellular carcinomas in cirrhosis: Clinicopathological study of resection or transplantation (1989) (6)
- Bone Lesion in a Patient with Transplanted Liver for a Metastatic Carcinoid. The Role of Somatostatin Receptor Scintigraphy (1998) (6)
- Pancreaticoduodenectomy in octogenarians: The importance of "biological age" on clinical outcomes. (2021) (6)
- Postrecurrence Survival After Liver Transplantation for Liver Metastases From Neuroendocrine Tumors (2021) (6)
- Abstract LB-233: IGF activation in a molecular subclass of hepatocellular carcinoma and preclinical efficacy of IGF-1R blockage (2010) (6)
- Preoperative serum levels of wild‐type and hepatitis B e antigen‐negative hepatitis B virus (HBV) and graft infection after liver transplantation for HBV‐related hepatocellular carcinoma (1997) (6)
- Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry (2021) (6)
- Mortality after Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry (2020) (6)
- Technical feasibility and short-term outcomes of laparoscopic isolated caudate lobe resection: an IgoMILS (Italian Group of Minimally Invasive Liver Surgery) registry-based study (2021) (6)
- Post-absorptive and insulin-mediated muscle protein metabolism in liver-transplanted patients (2002) (6)
- Management of Complications from Hepatobiliary Surgery Using the Percutaneous Trans Jejunal Approach (1997) (6)
- Perioperative Bevacizumab‐based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases (2019) (6)
- 94 Prospective randomised trial on IFN-therapy for the secondary prevention of HCC recurrence after curative resection in HCV related cirrhosis. Preliminary report (2004) (5)
- Multiagent imaging of liver tumors with reference to intra-arterial radioembolization (2013) (5)
- Psychosocial adaptation after liver transplantation with particular reference to recipients aware of their cancer. (1996) (5)
- External validation of an individual prognostic calculator after transarterial chemoembolization for hepatocellular carcinoma (2016) (5)
- Combined liver-islet allotransplantation in man under FK 506. (1991) (5)
- Hepatic resection for hepatocellular carcinoma (1993) (5)
- Endoscopic ultrasound-guided fine needle aspiration of splenic vein thrombosis: a novel approach to the portal venous system (2016) (5)
- ETOPOSIDE, CISPLATIN, EPIRUBICIN CHEMOTHERAPY IN THE TREATMENT OF PEDIATRIC LIVER TUMORS (2005) (5)
- Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study (2021) (5)
- Phase II Studies with Refametinib or Refametinib Plus Sorafenib in Patients with Mutant RAS Hepatocellular Carcinoma (HCC) (2016) (5)
- Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node negative intrahepatic cholangiocarcinoma. (2022) (5)
- Derazantinib (DZB) provides antitumor efficacy regardless of line of therapy in patients (pts) with FGFR2-fusion positive advanced intrahepatic cholangiocarcinoma (iCCA). (2019) (4)
- Impact of Surgical Margins on Overall Survival after Gastrectomy for Gastric Cancer: A Validation of Japanese Gastric Cancer Association Guidelines on a Western Series (2022) (4)
- Platinum sensitivity in patients with IDH1/2 mutated vs wild‐type intrahepatic cholangiocarcinoma: A propensity score‐based study (2022) (4)
- HEPATOTROPHIC EFFECTS OF FK 506 IN DOGS ! (2010) (4)
- Newest Therapies for Cholangiocarcinoma: An Updated Overview of Approved Treatments with Transplant Oncology Vision (2022) (4)
- Phenomenology and emotional impact of neuropsychiatric symptoms in orthotopic liver transplant for hepatocellular carcinoma. (2007) (4)
- In Vitro Evaluation of Rigosertib Antitumoral and Radiosensitizing Effects against Human Cholangiocarcinoma Cells (2021) (4)
- Liver transplantation as last-resort treatment for patients with bile duct injuries following cholecystectomy: a multicenter analysis (2020) (4)
- Quantitative assessment of the impact of COVID-19 pandemic on pancreatic surgery: an Italian multicenter analysis of 1423 cases from 10 tertiary referral centers (2021) (4)
- Combined liver and pancreatic islets transplantation in man using cyclosporin immunosuppression (1994) (4)
- Transplant Oncology in Primary and Metastatic Liver Tumors (2020) (4)
- HCC recurrence in HCV‐infected patients after liver transplantation: SiLVER Study reveals benefits of sirolimus in combination with CNIs – a post‐hoc analysis (2020) (4)
- Thirty-day mortality and five-year survival in thoracic surgery: “real-world” assessment of outcomes from a single-institution audit (2018) (3)
- Use of HBcAb Positive Liver Grafts. Medium Term Results According to Donor-Recipient Risk Factors (2011) (3)
- Correlation between dose and level of cyclosporine after orthotopic liver transplantation. (1989) (3)
- A modified technique of orthotopic transplant of the kidney in rabbits. (1989) (3)
- Radioembolization of Hepatocellular Carcinoma with 90Y Glass Microspheres: No Advantage of Voxel Dosimetry with Respect to Mean Dose in Dose–Response Analysis with Two Radiological Methods (2022) (3)
- Prognostic features of gastro‐entero‐pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties (2021) (3)
- Increased retinol binding protein in the sera of patients with severe ischemic damage of the liver after transplantation. (1998) (3)
- Corrigendum to “Current challenges in liver transplantation for hepatocellular carcinoma” [Best Pract Res Clin Gastroenterol 28 (2014) 867–879] (2014) (3)
- High pathologic response rate of hepatic colorectal cancer metastases (HCRM) following neoadjuvant bevacizumab (Bev)-based treatment (tx). (2013) (3)
- Predictive factors of HCC recurrence after liver transplantation (OLT): An interim analysis (2003) (3)
- Relationship between the dose and whole blood level of cyclosporine after liver and kidney transplantation. (1992) (3)
- Hepatocellular Carcinoma in Abernethy Malformation: A Rare Occurrence of Congenital Complete Portosystemic Shunt. (2018) (3)
- Surgical approach to the treatment of liver metastases from neuroendocrine tumors: Hepatic resection and liver transplantation (2010) (3)
- Carcinoma-Specific T Cells Expansion of Melanoma- and Colon Mediates In Vitro Activation and In Vivo Human Tumor-Derived Heat Shock Protein 96 (2003) (3)
- Temporal trends of waitlistings for liver transplantation in Italy: The ECALITA (Evolution of IndiCAtion in LIver transplantation in ITAly) registry study. (2022) (3)
- Milan multicenter experience in liver transplantation for hepatitis C-related cirrhosis: report of 105 cases. (1994) (3)
- Transthyretin RNA profiling in livers from transplanted patients affected by familial amyloidotic polyneuropathy, and identification of a dual transcription start point (2006) (3)
- Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials (2019) (3)
- Generation and Performance of Outcome Indicators in Liver Disease: The Value Based Medicine in Hepatology Study (VBMH) (2013) (3)
- Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial. (2022) (3)
- The prognostic effect of adequate lymphadenectomy in clinically node-negative patients undergoing liver resection for intrahepatic cholangiocarcinoma (2022) (3)
- Variations in risk‐adjusted outcomes following 4318 laparoscopic liver resections (2022) (3)
- INFINITY: A multicentre, single-arm, multi-cohort, phase II trial of tremelimumab and durvalumab as neoadjuvant treatment of patients with microsatellite instability-high (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC). (2023) (2)
- Abstract 2996: Overexpression of potential oncogenic microRNAs defines a new molecular subclass of hepatocellular carcinoma (2010) (2)
- Long‐term outcomes of resection versus transplantation for neuroendocrine liver metastases meeting the Milan criteria (2022) (2)
- Migration rate using fully covered metal stent in anastomotic strictures after liver transplantation: Results from the BASALT study group (2022) (2)
- Comparison between the difficulty of laparoscopic limited liver resections of tumors located in segment 7 versus segment 8: An international multicenter propensity‐score matched study (2022) (2)
- Inter-center agreement of mRECIST in transplanted patients for hepatocellular carcinoma (2021) (2)
- Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma (2015) (2)
- Exploiting liver immunity for the prevention of hepatic metastases. (2010) (2)
- Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETs. (2019) (2)
- 24 A NOVEL MOLECULAR CLASSIFICATION OF HCV-RELATED HEPATOCELLULAR CARCINOMA (HCC) BASED ON INTEGRATIVE GENOMIC ANALYSIS (2008) (2)
- Indocyanine Green Fluorescence-Guided Surgery for Gastrointestinal Tumors: A Systematic Review (2022) (2)
- No benefit after neoadjuvant chemoradiation in stage IV rectal cancer: A propensity score-matched analysis on a real-world population. (2021) (2)
- Well-differentiated neuroendocrine tumor of tailgut cyst. A rare entity with controversial medical opportunities (2013) (2)
- Authors’ response to the letter: Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours or portal hypertension by Zhong et al (2014) (2)
- Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma (2022) (2)
- Hepatic Surgeons Are Like the Child Who Rescued Dying Fish REPLY (2016) (2)
- Cyclosporine and liver regeneration studied byin vivo31P nuclear magnetic resonance spectroscopy (1991) (2)
- Approach to hepatic metastases from colorectal adenocarcinoma. (1988) (2)
- The role of a PAF-antagonist in experimental hyperacute rejection (HAR) (1988) (2)
- Y90-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers (2022) (2)
- MELD Inflation: The Current Hepatocellular Carcinoma Exception Policy is Primarily Responsible for Steadily Increasing MELD Scores at the Time of Liver Transplant in All Regions of the U.S (2013) (2)
- The Protective Effect of SRI 63-441 on Ischemic Liver Injury Using the Isolated Perfused Rat Liver: Combined Protocol With Superoxide Dismutase. (1988) (2)
- Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma. (2022) (2)
- 141Non-hepatic glucose production in humans during the anhepatic phase of liver transplantation (2000) (2)
- Effect of liver transplantation in cirrhotic diabetic patients. (1998) (2)
- O100 DISCOVERY OF NOVEL MUTATIONS AND FUSION PROTEINS IN INTRAHEPATIC CHOLANGIOCARCINOMA (2014) (2)
- Defining Global Benchmarks for Laparoscopic Liver Resections (2022) (2)
- Perioperative triplet chemotherapy plus bevacizumab (bev) in patients with borderline resectable colorectal cancer liver metastases (CLM): Preliminary safety and activity (2016) (1)
- Loss of succinate dehydrogenase (SDHB) in midgut carcinoids as a prognostic factor: A new marker of personalized cancer medicine in neuroendocrine tumors? (2013) (1)
- Successful liver transplantation from a donor with chromosomal abnormality (45,XO). (1994) (1)
- 389 LOW RISK OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION: A 3-YEAR FOLLOW-UP STUDY IN 78 PATIENTS WITH CHRONIC HEPATITIS B (2008) (1)
- P1281 GENERATION AND PERFORMANCE OF VALUE-BASED OUTCOME INDICATORS IN LIVER DISEASE: THE MULTICENTER V.B.M.H. STUDY (2014) (1)
- Regorafenib improves survival after sorafenib in patients with recurrent HCC after liver transplantation (2021) (1)
- 1180P Single-institution real-life experience of 177Lu-DOTATATE treatment in progressive, well differentiated GEPNETs (2020) (1)
- 1146PMETFORMIN IMPACT ON PROGRESSION-FREE SURVIVAL IN ADVANCED PANCREATIC WELL-DIFFERENTIATED NEUROENDOCRINE TUMORS (PWDNETS). RETROSPECTIVE EVALUATION IN DIABETIC PATIENTS RECEIVING EVEROLIMUS PLUS OCTREOTIDE LAR TREATMENT. (2014) (1)
- HEPATIC EPITHELIOID HEMANGIO-ENDOTHELIOMA AND ADULT LIVER TRANSPLANTATION: PROPOSAL FOR A PROGNOSTIC SCORE BASED ON THE ANALYSIS OF THE ELTR-ELITA REGISTRY. (2016) (1)
- Resection of Retro-Hepatic Vena Cava (RHVC) En-bloc with Caudate Lobe without Vascular Exclusion for a Low Grade Leiomyosarcoma of Inferior Vena Cava (2021) (1)
- Reply Refers to Predicting Outcomes of Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma (2018) (1)
- Safety and effectiveness of Regorafenib in recurrent HCC after liver transplantation and progression on Sorafenib: a real-life multicentre study (2019) (1)
- Reply to: "Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue". (2014) (1)
- Post-hoc analysis of CLARINET phase III study to investigate the influence of diabetic status on progression-free survival (PFS) of patients with neuroendocrine tumours (NETs) treated with lanreotide (LAN) or placebo (PBO). (2018) (1)
- Comp arative efficacy of sorafenib vs. best supporti ve care in recurren t hepat ocellula r carcinoma after liver tran splantation: A case-contro l study (2013) (1)
- 2 DISRUPTION OF IGF SIGNALING IN EARLY HEPATOCELLULAR CARCINOMA AND PRE-CLINICAL EFFICACY OF ANTI-IGF1R BLOCKING THERAPIES (2008) (1)
- Liver transplantation for intrahepatic recurrence of hepatocellular carcinoma in non-cirrhotic livers after partial liver resection (2007) (1)
- Comparison Between Swan-Ganz Catheter and Minimally Invasive Hemodynamic Monitoring During Liver Transplantation: Report of a Monocentric Case Series. (2019) (1)
- Reply (2016) (1)
- The impact of metformin on progression-free survival of patients with advanced pancreatic well-differentiated neuroendocrine tumor receiving everolimus plus somatostatin analog treatment. (2014) (1)
- [Hepatogenic diabetes]. (2001) (1)
- Abstract 2936: Molecular characterization of the immune subclass of hepatocellualr carcinoma (2017) (1)
- Post-liver transplant intrahepatic cholestasis (2017) (1)
- Impact of tumor size on the difficulty of laparoscopic left lateral sectionectomies. (2022) (1)
- Molecular characterization of the immune class of hepatocellular carcinoma (2017) (1)
- Milan multicenter experience in 96 liver transplants for hepatitis B virus-related cirrhosis. (1994) (1)
- 36 OPTIMIZATION OF DONOR-RECIPIENT MATCH AND IDENTIFICATION OF THE FUTILE MATCH CUTOFF. A NATIONAL ITALIAN STUDY ON LIVER TRANSPLANTATION (2011) (1)
- Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria (2022) (1)
- Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients with Metabolic Syndrome. (2023) (0)
- 30 Radiological-pathological correlation of small HCC treated with radiofrequency (RITA) before liver transplantation (2000) (0)
- Rigosertib as a radio-sensitizer for concurrent chemo-radiation treatment of cholangiocarcinoma (CCA): a comparative study in vitro (2017) (0)
- Laparoscopic liver resection of hepatocellular carcinoma located in unfavaroble segments: a propensity score-matched analysis from the Italian group of minimally invasive liver surgery registry (2018) (0)
- Liver transplantation for hepatocellular carinoma (HCC): Predictive factors of HCC recurrence, an interim analysis (2003) (0)
- 171 Reinfection of liver graft by hepatitis B virus in transplant recipients with occult hepatitis B (2004) (0)
- Milan criteria, up-to-seven criteria, and the illusion of a rescue package for patients with liver cancer – Authors' reply (2009) (0)
- 266 Evidence of hedgehog signaling pathway activation in hepatocellular carcinoma (2006) (0)
- Predictors of Late Recurrence after Liver Resection for Hepatocellular Carcinoma on Non-Alcoholic Fatty Liver Disease (2016) (0)
- Improving Outcome of Selected Patients With Non-Resectable Hepatic Metastases From Colorectal Cancer With Liver Transplantation: A Prospective Parallel Trial (COLT trial). (2023) (0)
- Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma (2020) (0)
- Long Term Survival Analysis in a Cohort of 125 Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using Small Drug Eluting Beads (2021) (0)
- Correction to: Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry (2021) (0)
- Adjuvant radiotherapy in urothelial neuroendocrine carcinoma. (2020) (0)
- Carcinoid syndrome (2004) (0)
- Flow cytometry characterization of stem cell lineages in the liver of patients with hepatic tumors (2008) (0)
- 429: INNATE IMMUNITY IN COLORECTAL LIVER METASTASES: MACROPHAGE MORPHOLOGY AND DISTRIBUTION ARE STRONG PREDICTORS OF PROGNOSIS. AN EXTERNAL VALIDATION. (2022) (0)
- Short Communication Importance of early nutritional screening in patients with gastric cancer (2011) (0)
- protocolA prospective randomised , open-labeled , trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma (2010) (0)
- The role of modulation of somatostatin analogues (SSAs) in association to peptide receptor radionuclide therapy (PRRT) after SSAs progression disease (PD) in advanced well-differentiated (WD) entero-pancreatic neuroendocrine tumours (EP-NETs). (2018) (0)
- 457PPredictive factors in GEP-NEN: The integrated role of Ki67, beta-catenin and morphology (2017) (0)
- www.D-MELD.com. THE ONLINE PROGNOSTIC CALCULATOR TO OPTIMIZE DONOR-RECIPIENT MATCH (2011) (0)
- SERUM ALPHA-FETOPROTEIN MODIFICATION (DELTA-AFP) IS A HIGHLY SPECIFIC TOOL TO SUSPECT HCC RECURRENCE AFTER LIVER TRANSPLANTATION (2015) (0)
- Impact of body mass index on the difficulty and outcomes of laparoscopic left lateral sectionectomy (2023) (0)
- A method for establishing allocation equity among patients with HCC Vitale J Hepatology 14 (2014) (0)
- J-Pharmacologic Modulation of Experimental Postischemic Hepatic Function (0)
- Hepatic stem cell characterization in tumoral and non-tumoral liver specimens from patients with hepatocellular carcinoma (2009) (0)
- THE PLACE OF LIVER TRANSPLANTATION IN THE TREATMENT OF HEPATIC EPITHELOID HAEMANGIOENDOTHELIOMA: REPORT OF THE EUROPEAN LIVER TRANSPLANT REGISTRY (ELTR): 620 (2008) (0)
- P0386 : Predicting liver decompensation after resection for hepatocellular carcinoma: A recursive partitioning analysis of prognostic factors (2015) (0)
- Sub-classification of laparoscopic left hepatectomy based on hierarchic interaction of tumor location and size with perioperative outcomes. (2023) (0)
- Reply to: "Time is a crucial factor for the use of oncological treatment for post-transplantation recurrence of hepatocellular carcinoma". (2014) (0)
- Risk adjusted benchmarks in laparoscopic liver surgery: Data from the Italian group of minimally invasive liver registry (2020) (0)
- Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis (2018) (0)
- 122 GENOME-BASED MODELING PROGNOSIS IN HEPATOCELLULAR CARCINOMA: PROLIFERATION-G3 AND ADJACENT POOR SIGNATURES INDEPENDENTLY PREDICT RECURRENCE (2010) (0)
- P999 Y90-RADIOEMBOLIZATION FOR INTERMEDIATE/ADVANCED HCC PATIENTS OUTSIDE THE CONVENTIONAL CRITERIA MAY BE DETRIMENTAL: A SINGLE CENTER EXPERIENCE (2014) (0)
- Abstracts of the 64th Annual Meeting of the American Association for the Study of Liver Diseases: the Liver Meeting 2013. November 1-2, 2013. Washington, D.C., USA. (2013) (0)
- G05 : Exome sequencing of 243 liver tumors identifies new mutational signatures and potential therapeutic targets (2015) (0)
- PC.01.1 MANAGEMENT OF BILIARY ANASTOMOTIC STRICTURE AFTER LIVER TRANSPLANTATION (BASALT STUDY): RESULTS OF A NATIONAL SURVEY IN ITALY (2016) (0)
- High donor-age vs High MELD in liver Tx. Which is the most effective approach? Evidences from the Italy-US D-MELD study (2014) (0)
- The effect of cyclosporine on the metabolic response to fructose and on liver regeneration in dog after portacaval shunt: In vivo 31P-NMR spectroscopy (1989) (0)
- Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis (2022) (0)
- 26 Liver transplantation for hepatocellular carcinoma (HCC): Predictive factors of HCC recurrence, an interim analysis (2003) (0)
- HCC recurrence following liver tranplantation should be aggresively treated to increase patient survival (2016) (0)
- Hepatic Epithelioid Haemangio-Endothelioma and Adult Liver Transplantation: Extra-Hepatic Disease iI Not a Contraindication to Liver Transplantation. Report of the European Liver Transplant Registry Including 149 Patients (2016) (0)
- Liver Resection and Transplantation for Metastases from Gastroenteropancreatic Neuroendocrine Tumors (2020) (0)
- C.345 - Truly dosimetric treatment planning with 99m-TC MAA SPECT prolonged overall survival in radioembolization of hepatocarcinoma with 90-y glass microspheres (2016) (0)
- Impact of neoadjuvant chemotherapy on the difficulty and outcomes of laparoscopic and robotic major liver resections for colorectal liver metastases: A propensity-score and coarsened exact-matched controlled study. (2023) (0)
- P0265 : IGF2 is an oncogenic driver in HCC and emerges as a potential target for therapies (2015) (0)
- Polyploidy and chromosomal instability correlates with proliferative traits and lack of immune-related gene signatures in hepatocellular carcinoma (2018) (0)
- Clinical and molecular determinants of extrahepatic disease progression (ePD) in initially unresectable, liver limited metastatic colorectal cancer (mCRC). (2018) (0)
- Gene expression profiles of pre-neoplastic lesions and hepatocellular carcinoma in hepatitis C virus -cirrhotic patients (2005) (0)
- Increased intestinal permeability and inflammation are associated with hepatocellular carcinoma in patients with NAFLD-related liver cirrhosis (2018) (0)
- O93 GENE EXPRESSION-BASED PROGNOSTIC SIGNATURE AND GENOMIC CHARACTERIZATION OF FIBROLAMELLAR HEPATOCELLULAR CARCINOMA (2014) (0)
- F-46 Graft survival is worse in HCV positive females transplanted with male donor grafts (2012) (0)
- 66P Preoperative predictors of long-term outcomes for resectable intrahepatic cholangiocarcinoma (iCCA): Is there a space for neoadjuvant? (2020) (0)
- Precision medicine targeting disrupted IGF signaling in hepatoblastoma (2018) (0)
- Liver transplantation for human immunodeficiency virus-Infected patients with hepatocellular carcinoma (2017) (0)
- Quantitation and typing of hepatitis C Virus RNA in patients on interferon and ribavirin prophylaxis after liver transplantation (1995) (0)
- Clinical and molecular determinants of extrahepatic disease progression (ePD) in initially unresectable, liver-limited metastatic colorectal cancer (mCRC). (2018) (0)
- The un-sustainable match in HCV recipients : Evidences from the italian D-MELD study on balancing donor-recipent risk factors (2012) (0)
- Can liver transplantation or hepatic resection achieve cure for hepatocellular carcinoma (2018) (0)
- MUTATIONS WITHIN THE CD- BINDING SITES AND HYPERVARIABLE REGION OF THE ENVELOPE PROTEIN AND HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION (2003) (0)
- Surgical Treatment of Hepatocellular Carcinoma: Multicenter Competing-risk Analysis of Tumor-related Death Following Liver Resection and Transplantation Under an Intention-to-treat Perspective. (2023) (0)
- ASO Author Reflections: Amid Anatomic Restrictions, Three-Dimensional Surgical Planning Eases En Bloc Resection of the Retro-Hepatic Vena Cava and the Caudate Lobe of the Liver (2021) (0)
- Short and long-term outcomes after minimally invasive liver resection for single small hepatocellular carcinoma: An analysis of 714 patients from the IGoMILS (Italian group of minimally invasive liver surgery) registry. (2023) (0)
- Experience with radiofrequency ablation of hepatocellular carcinoma in patients awaiting liver transplantation (2003) (0)
- ASO Visual Abstract: Impact of Surgical Margins on Overall Survival After Gastrectomy for Gastric Cancer: A Validation of Japanese Gastric Cancer Association Guidelines on a Western Series (2022) (0)
- Correction to: Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study (2021) (0)
- Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open Issues (2023) (0)
- 85. Treatment of hepatocarcinoma with 90Y glass microspheres: Safety and indication of prolonged overall survival thanks to two compartment dosimetric treatment planning (2018) (0)
- Refinining the post transplant outcomes prediction of Metroticket 2.0 through mRECIST criteria (2020) (0)
- MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers (2022) (0)
- 839 CHARACTERIZATION OF STEM CELL COMPARTMENTS IN ADULT HUMAN LIVER (2009) (0)
- 133 DYSREGULATION OF FIBROBLAST GROWTH FACTOR NETWORK IN EARLY HEPATOCELLULAR CARCINOMA (2011) (0)
- Author response for "Gastro‐entero‐pancreatic neuroendocrine neoplasms ‐ prognostic features in primary and metastatic sites: grade, mesenteric tumor deposits and emerging novelties" (2021) (0)
- Reply to: "Validation of response to yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion". (2018) (0)
- Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma. (2022) (0)
- Propensity-score Matched and Coarsened-exact Matched Analysis Comparing Robotic and Laparoscopic Major Hepatectomies: An International Multicenter Study of 4822 Cases. (2023) (0)
- Model to predict major complications following liver resection for HCC in patients with metabolic syndrome (2023) (0)
- Characterization of stem cell compartments in adult human liver (2009) (0)
- P997 NON SUPERIORITY OF DRUG-ELUTING BEADS WITH RESPECT TO CONVENTIONAL TRANSARTERIAL CHEMOEMBOLIZATION FOR THE TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA: A PROPENSITY SCORE ANALYSIS (2014) (0)
- Studies of the Hepatotrophlc Qualities of FK 506 and eyA (2010) (0)
- 466 IGF2 drives IGF oncogenic signaling in HCC and emerges as a potential target for therapies (2014) (0)
- Transplantation in Patients with Previous Portasystemic Shunt (2010) (0)
- High MELD vs High Donor Age: Two Different Approaches, Similar Results. Evidences from US and Italy (2013) (0)
- Controversy on the role of FoxP3 + regulatory T cells in fibrogenesis in chronic hepatitis C virus infections (2014) (0)
- Flow cytometry enumeration and characterization of stem cell lineages in the liver of patients with hepatic tumors (2007) (0)
- Macrophage morphology and distribution are strong predictors of prognosis in resected colorectal liver metastases: results from an external retrospective observational study. (2023) (0)
- P1000 CLINICAL OUTCOMES AND SAFETY PROFILE OF TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA WITH SMALL (70–150 µM, M1) DRUG ELUTING BEADS: A PHASE I STUDY (2014) (0)
- Regorafenib improves survival after sorafenib treatment in patients with recurrent hepatocellular carcinoma after liver transplantation, compared to best supportive care (2020) (0)
- Renal‐splenic shunt for intrahepatic caval occlusion after piggy‐back liver transplantation (1997) (0)
- Survival Benefit Of Lymphadenectomy For Intrahepatic Cholangiocarcinoma: It Might Be Gold Even If It Does Not Glitter. (2023) (0)
- Prospective randomized trial for hormonal-targeted therapy in advanced hepatocellular carcinoma (2003) (0)
- Abstract 3517: Targeting pH regulators to modulate human hepatocellular carcinoma microenvironment (2018) (0)
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma : Subanalyses of a phase III trial q , qq (2012) (0)
- OC-28 Behind D-MELD: the role of primary indication (HCV or HBV) as significant covariate in the outcome prediction after liver transplants (2012) (0)
- Development and validation of a survival calculator for hepatocellular carcinoma patients undergoing liver transplantation: the Metroticket 2.0 model (2017) (0)
- Can the Un-Sustainable Match Be Identified in Liver Transplant Population? Evidencies from the Italian Donor-2-Recipient D-Meld Study: 2566 (2012) (0)
- Table of Contents (2020) (0)
- Clinical Options for Treatment of Hepatocellular Carcinoma (2018) (0)
- Preliminary safety and efficacy of perioperative COI-B (capecitabine, oxaliplatin, irinotecan, and bevacizumab) in patients with borderline resectable or high–recurrence risk colorectal cancer liver metastases (CLM). (2016) (0)
- Preliminary safety and activity of perioperative triplet chemotherapy plus bevacizumab (bev) in patients with borderline resectable colorectal cancer liver metastases (CLM). (2016) (0)
- Experience with liver transplantation for hepatocellular carcinoma (1997) (0)
- Development of a model based on case-mix analysis to predict 6-month patient survival after liver transplantation: a multicenter Italian study (2019) (0)
- T06.02.14 ENDO-THERAPIES FOR BILIARY DUCT-TO-DUCT ANASTOMOTIC STRICTURE AFTER LIVER TRANSPLANTATION: IMPACT OF A NATIONAL AUDIT PROGRAM (BASALT STUDY GROUP) (2020) (0)
- Utility of the Iwate difficulty scoring system for laparoscopic right posterior sectionectomy: do surgical outcomes differ for tumors in segments VI and VII? (2022) (0)
- Complete peritonectomy associated with intra peritoneal hyperthermic perfusion in the treatment of Pseudomyxoma Peritonei: experience at the National Cancer Institute of Milan (1999) (0)
- 890 HETEROGENEITY IN PRIMARY HUMAN HEPATOCELLULAR CARCINOMA IS DUE TO DIFFERENT SUBSETS OF CANCER STEM-LIKE CELLS WITHIN THE TUMOUR (2010) (0)
- Robotic versus laparoscopic liver resection for huge (≥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases (2023) (0)
- Effect of alpha-fetoprotein on survival in HIV-infected patients with hepatocellular carcinoma (2019) (0)
- Refining the immune class of hepatocellular carcinoma (2020) (0)
- Abstract #444: Molecular and clinical characterization of RICTOR (MTORC2) as a candidate oncogene in hepatocellular carcinoma (2009) (0)
- O053 HOME ENTERAL NUTRITION IN MALNOURISHED PATIENTS AFFECTED BY GASTROINTESTINAL MALIGNANCY (2008) (0)
- Relative Survival Instead of Overall Survival Should Be Used as Outcome When Analyzing the Effect of Age After Treatment of Hepatocellular Carcinoma. (2018) (0)
- Erratum to ''A method for Liver Liver transplantation NITp working group Erratum (2013) (0)
- Association between HLA class I and class II alleles and HCV, HBV infection in patients with hepatocellular carcinoma (2001) (0)
- Production of EVs , Lipophilic Dye loaded EVs and Indocyanine green loaded EVs (2019) (0)
- Increased Sensitivity of Computed Tomography Scan for Neoplastic Tissues Using the Extracellular Vesicle Formulation of the Contrast Agent Iohexol (2022) (0)
- Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry. (2023) (0)
- Reply: (2013) (0)
- D15Patients with borderline resectable colorectal cancer liver metastases (CLM): preliminary safety and activity of perioperative triplet chemotherapy plus bevacizumab (bev) (2016) (0)
- Abstract 1387: The importance of FGF pathway in hepatocellular carcinoma and its role in acquired resistance to anti-angiogenic therapies (2012) (0)
- Radiofrequency ablation (RFA) and combined hepatic arterial ischemia (HAI) for unresectable 3–6 cm hepatocellular carcinoma (HCC): A prospective study (2003) (0)
- Development and validation of an on-line web calculator for survival after trans-arterial chemo-embolization for hepatocellular carcinoma (2016) (0)
- 21 HETEROGENEITY OF STEM-LIKE CELLS IN HEPATOCELLULAR CARCINOMA (2010) (0)
- D-MELD PREDICTION OF GRAFT SURVIVAL AFTER DECEASED DONOR LIVER TRANSPLANTATION. RESULTS OF THE ITALIAN RETROSPECTIVE MULTICENTER DONOR-RECIPIENT MATCH STUDY.: 1899 (2010) (0)
- 8Experience with liver transplantation for hepatocellular carcinoma in cirrhosis (2000) (0)
- Development of a Prognostic Scoring System for Patients Undergoing Liver Resection for Hepatocellular Carcinoma (2016) (0)
- Setting up of a national liver transplant programme for neuroendocrine tumour liver metastases in UK and Ireland: opportunities for clinical study and research (2021) (0)
- 110 MOLECULAR AND CLINICAL CHARACTERIZATION OF RICTOR (MTORC2) AS A CANDIDATE ONCOGENE IN HEPATOCELLULAR CARCINOMA (2009) (0)
- Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) (2014) (0)
- Endoscopic ultrasound-guided fine needle aspira- tion of splenic vein thrombosis: a novel approach to the portal venous system (2016) (0)
- Resting energy expenditure in diabetic and nondiabetic patients with liver cirrhosis : relation with insulin sensitivity and effect of liver transplantation and immunosuppressive therapy 1 – 3 (2002) (0)
- P973 VALUE-BASED APPROACH TO HEPATOCELLULAR CARCINOMA: OUTCOME INDICATORS TESTED IN A LARGE MULTICENTER STUDY (VBMH STUDY) (2014) (0)
- 125Experience with interferon-α2B and ribavirin prophylaxis after liver transplantation in HCV-RNA positive recipients (2000) (0)
- Abstract 474: Genome-wide DNA methylation profiling reveals novel candidate epigenetic gatekeepers in hepatocarcinogenesis (2019) (0)
- ASO Author Reflections: Less is more: Organ-Sparing Approach for the Surgical Treatment of Gastric Adenocarcinoma (2022) (0)
- 206 THE UN-SUSTAINABLE MATCH IN HCV LIVER TRANSPLANT PATIENTS (2012) (0)
- Improved management of grade B biliary leaks after complex liver resections using gadoxetic acid disodium-enhanced magnetic resonance cholangiography. (2021) (0)
- Abstract LB-232: Derazantinib (ARQ 087) pharmacodynamics: Alterations in FGF19/21/23 and phosphate in patients with cholangiocarcinoma (2018) (0)
- DYSREGULATION OF TUMOR SUPPRESSOR KLF6 INCREASES HCC RELATED MORTALITY IN HCV INFECTED PATIENTS AND INCIDENCE OF TUMOR IN MOUSE MODEL OF HEPATIC CARCINOGENESIS (2009) (0)
- OC.01.6 A NEW FULLY COVERED SELF-EXPANDABLE METAL FOR ENDOSCOPIC TREATMENT OF POST-OLT BILIARY ANASTOMOTIC STRICTURES (AD INTERIM EVALUATION) (BASALT STUDY) (2020) (0)
- 1183P Sequential PRRT and SIRT: Evaluation of safety, toxicity and best sequence treatment in liver dominant GEPNETs (2020) (0)
- Acquired Resistance Mechanisms to PD-L1 Blockade in a Patient With Microsatellite Instability-High Extrahepatic Cholangiocarcinoma. (2022) (0)
- PS-048-Definition of aneuploidy profiles and their impact on tumour progression and immune features in hepatocellular carcinoma (2019) (0)
- FRI-473-Safety and effectiveness of regorafenib in recurrent HCC after liver transplantation and progression on sorafenib: A real-life multicentre study (2019) (0)
- Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Vincenzo Mazzaferro?
Vincenzo Mazzaferro is affiliated with the following schools:
